Possible estuary-associated syndrome: Symptoms, vision, and treatment

Environmental Health Perspectives

Volumn 109, Issue 5, 2001, Pages 539-545

  Shoemaker, Ritchie C ^a   Hudnell, H Kenneth ^b  

^a McCready Outpatient Services Center   (United States)

^b U S ENVIRONMENTAL PROTECTION AGENCY   (United States)

Author keywords

Cholestyramine; Chronic neurotoxic illness; Harmful algal blooms; Pfiesteria; Possible estuary associated syndrome; Visual contrast sensitivity

Indexed keywords

ANTIBIOTIC AGENT; ANTIDOTE; COLESTYRAMINE; NEUROTOXIN; PLACEBO; WATER;

ACUTE DISEASE; ADULT; AGED; ARTICLE; CASE STUDY; CHRONIC DISEASE; CLINICAL ARTICLE; CLINICAL EXAMINATION; CLINICAL FEATURE; CONTROLLED STUDY; DIAGNOSTIC PROCEDURE; DINOFLAGELLATE; DISEASE ASSOCIATION; DISEASE CLASSIFICATION; DISEASE CONTROL; DRUG EFFICACY; ENVIRONMENTAL EXPOSURE; ESTUARY; FEMALE; FISH; HEALTH CARE ORGANIZATION; HUMAN; MALE; NONHUMAN; PATIENT MONITORING; PFIESTERIA; POSSIBLE ESTUARY ASSOCIATED SYNDROME; PRIORITY JOURNAL; PROTOZOAL INFECTION; SYMPTOMATOLOGY; SYNDROME; TREATMENT OUTCOME; VISUAL DISCRIMINATION; WATER CONTAMINATION;

ALGAE; DINOPHYCEAE; PFIESTERIA; PFIESTERIA PISCICIDA; PFIESTERIA SHUMWAYAE; PISUM SATIVUM; PROTOZOA;

EID: 0035325237     PISSN: 00916765     EISSN: None     Source Type: Journal    
DOI: 10.1289/ehp.01109539     Document Type: Article

References (52)

1. Summary of Maryland Pfiesteria Sampling and Results
2. 2000 Biennial Report of the Secretary of Natural Resources to the Virginia General Assembly. Chesapeake Bay and Its Resources: Results of Monitoring Programs and Status of Resources
3. Fish Health Activity, DNA Results and Ancillary Data
4. Heteroduplex mobility assay-guided sequence discovery: Elucidation of the small subunit (18S) rDNA sequence of Pfiesteria piscicida and related dinoflagellates from complex algal culture and environmental sample DNA pools
5. Back Creek 1999: Pfiesteria Laboratory Results
6. The influence of vision on computerized neurobehavioral test scores: A proposal for improving test protocols
7. The importance of stimulus selection in VEP practice: The clinical relevance of visual physiology
8. New phantom dinoflagellate is the causative agent of major estuarine fish kills
9. Novel toxic dinoflagellate causes epidemic disease in estuary fish
10. The Biology of the Toxic Pfiesteria Complex in the Neuse Estuary, North Carolina
11. Fish kills linked to a toxic ambush-predator dinoflagellate: Distribution and environmental conditions
12. Insidious effects of a toxic estuarine dinoflagellate on fish survival and human health
13. Diagnosis of Pfiesteria human illness syndrome
14. Learning and memory difficulties after environmental exposure to waterways containing toxin-producing Pfiesteria or Pfiesteria-like dinoflagellates
15. Human visual function in the North Carolina Clinical Study on Estuary Associated Syndrome
16. Notice to readers: Possible estuary associated syndrome
17. Reporter gene assay for fish-killing activity produced by Pfiesteria piscicida
18. A cohort study to determine the epidemiology of estuary-associated syndrome
19. Treatment of persistent Pfiesteria-human illness syndrome
20. A new contrast sensitivity vision test chart
21. Large sample norms for contrast sensitivity
22. Segregation of form, color, movement and depth: Anatomy, physiology and perception
23. Visual contrast sensitivity deficits in Bohemian children
24. Behavioral neurophysiology: Quantitative measures of sensory toxicity
25. Treatment of possible estuary-associated syndrome: Neurotoxins, contrast sensitivity and cholestyramine
26. Cholestyramine: Use as a new therapeutic approach for chlordecone (kepone) poisoning
27. Treatment of chlordecone (kepone) toxicity with cholestyramine. Results of a controlled clinical trial
28. Reduction in the body content of DDE in the Mongolian gerbil treated with sucrose polyester and caloric restriction
29. Recognition and Management of Pesticide Poisoning
30. Pharmacokinetics of halogenated hydrocarbons
31. Multiple relapses on Clostridium difficile-associated diarrhea in a cancer patient: Successful control with long-term cholestyramine therapy
32. Whole-bowel irrigation as an adjunct to the treatment of chronic, relapsing Clostridium difficile colitis
33. Etude experimental chez le lapin de l'effet de la cholestyramine dans le traitement des diarrhees infectieuses d'origine cholerique
34. La Cholestyramine fixe les toxines d'escherichia coli et de vibrio cholerae par une liaison ionique
35. Partial purification of a toxin found in hamsters with antibiotic-associated colitis. Reversible binding of the toxin by cholestyramine
36. Collagenous colitis: Are bacterial cytotoxins responsible?
37. Prevention of nephrotoxicity of ochratoxin A, a food contaminant
38. Dietary cholestyramine reduces ochratoxin A-induced nephrotoxicity in the rat by decreasing plasma levels and enhancing fecal excretion of the toxin
39. Cholestyramine as a Binding Agent for Detoxification of Fumonisins: In vitro Studies and Determination of Its Effectiveness in Rat Feeding Experiments
40. A model system for studying the bioavailability of intestinally administered microcystin-LR, a hepatotoxic peptide from the cyanobacterium Microcystis aeruginosa
41. Effectiveness of cholestyramine in the detoxification of zearalenone as determined in mice
42. Jin Bu Huan toxicity in adults-Los Angeles, 1993
43. Cholestyramine protection against ochratoxin A (OTA) toxicity: Role of OTA adsorption by the resin and bile acid enterohepatic circulation
44. Purification and characterization of ciguatoxins from moray eel (Lycondontis javanicus, Muraenidae)
45. Reaction of ammonium cations with 18-crown-6
46. Doctor claims drug can help people exposed to Pfiesteria
47. Toxin isolation and characterization
48. Characterization of a P2X7 ionotropic receptor for the putative Pfiesteria toxin and its role in chronic inflammatory responses
49. The N-methyl-D-asparate neuro-transmitter receptor is a mammalian brain target for the dinoflagellate Pfiesteria piscicida toxin